BioRestorative Therapies (BRTX) Interest Income - Total (2023 - 2025)
BioRestorative Therapies' (BRTX) quarterly Interest Income - Total came in at $34695.0 in Q4 2025, down 73.58% on a YoY basis from $131325.0 in Q4 2024, and down 41.53% quarter-over-quarter from $59336.0 in Q3 2025.
Analysis
BioRestorative Therapies (BRTX) Interest Income - Total (2023 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has reported Interest Income - Total for 3 consecutive years, with $34695.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Interest Income - Total fell 73.58% year-over-year to $34695.0; the trailing twelve-month figure through Dec 2025 stood at $270573.0 (down 56.63% YoY), and the FY2025 full-year result was $270573.0, down 56.63% from the prior year.
- Interest Income - Total fell to $34695.0 in Q4 2025 per BRTX's latest filing, from $59336.0 in the prior quarter.
- Across five years, Interest Income - Total topped out at $402202.0 in Q4 2023 and bottomed at -$39292.0 in Q3 2023.
- Historically, Interest Income - Total has averaged $121953.5 across 3 years, with a median of $117062.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Interest Income - Total soared 520.98% in 2024, then sank 73.58% in 2025.
- Over 3 years, Interest Income - Total stood at $402202.0 in 2023, then tumbled by 67.35% to $131325.0 in 2024, then plunged by 73.58% to $34695.0 in 2025.
- According to Business Quant data, Interest Income - Total over the past three periods registered $34695.0, $59336.0, and $73743.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Total (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | - |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | - |
| 10 | BioRestorative Therapies | 62,133.68 | -2.89 Mn | 17,964.00 | 34,695.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 34,695.00 |
| Dec 31, 2025 | 34,695.00 |
| Sep 30, 2025 | 59,336.00 |
| Sep 30, 2025 | 59,336.00 |
| Jun 30, 2025 | 73,743.00 |
| Jun 30, 2025 | 73,743.00 |
| Mar 31, 2025 | 102,799.00 |
| Mar 31, 2025 | 102,799.00 |
| Dec 31, 2024 | 131,325.00 |
| Dec 31, 2024 | 131,325.00 |
| Sep 30, 2024 | 165,411.00 |
| Sep 30, 2024 | 165,411.00 |
| Jun 30, 2024 | 175,469.00 |
| Jun 30, 2024 | 175,469.00 |
| Mar 31, 2024 | 151,596.00 |
| Mar 31, 2024 | 151,596.00 |
| Dec 31, 2023 | 402,202.00 |
| Dec 31, 2023 | 402,202.00 |
| Sep 30, 2023 | -39,292.00 |
| Sep 30, 2023 | -39,292.00 |